Abstract
Background Approximately 50% of out-of-hospital Sudden Cardiac Arrest (SCA) occurs in people with unrecognized SCA-risk and no preceding cardiologic care records. General practitioner (GP) records include these people, specifically people with type 2 diabetes (T2D) with increased SCA-risk. We aimed to provide a proof-of-concept for using routine primary care data to study SCA-risk in people with T2D.
Methods This case-control study, identified SCA cases through the AmsteRdam REsuscitation STudies (ARREST) registry of out-of-hospital SCA in the Dutch region of Noord-Holland (2005-2019). We included cases with presumed cardiac cause and T2D registered at participating GP practices from the PHARMO Data Network and the academic network of general practice Amsterdam UMC (ANHA). Cases were matched (age, sex, T2D, GP-practice) with up to five non-SCA controls. From their GP files, we collected clinical measurements, medication use and medical history. Associations with SCA were analysed using univariable and multivariable conditional logistic regression (Odds Ratios, 95% confidence intervals).
Results We included 247 cases and 1,143 controls. In the multivariable model, high fasting glucose (1.08 (1.01-1.16) per 1 mmol/L), high cholesterol ratio (1.17 (1.03-1.34)), moderate albuminuria (2.77 (1.84-4.16)), severe albuminuria (2.96 (1.44-6.08)), dyslipidaemia (0.53 (0.33-0.86)) and a history of cardiovascular disease (1.72 (1.23-2.17)) were significantly associated with SCA. Current smoking behaviour, decreased eGFR, insulin use, hypertension and microvascular complications were close to significantly associated with SCA.
Conclusions The relatively strong associations in our small sample are consistent with those found in cardiologic care populations, indicating that GP file data can be useful to study SCA-risk.
Competing Interest Statement
The authors had full autonomy in the design, conduct, and reporting of the manuscript. KMAS is an employee of the PHARMO Institute for Drug Outcomes Research. This independent research institute performs financially supported studies for government and related healthcare authorities and several pharmaceutical companies. The other authors declare no conflicts of interest.
Funding Statement
This work was supported with funding by the Dutch Heart Foundation grant CVON2017-15 RESCUED, the European Union's Horizon 2020 research and innovation program under acronym ESCAPE-NET (registered under grant agreement No 733381), COST Action PARQ under grant agreement No CA19137 supported by COST (European Cooperation in Science and Technology) and Amsterdam University Medical Centers. The ARREST registry is supported by an unconditional grant of Stryker, Emergency Care, Redmond WA, USA. The study funders were not involved in the design of the study; the collection, analysis, and interpretation of data or writing the report. The only restriction imposed was Open Access publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The medical ethical review committee (METC) of the Amsterdam UMC, location AMC gave ethical approval for the ARREST study part of this work (decision no.: 2017_260) The medical ethical review committee (METC) of the Amsterdam UMC, location VUmc waived ethical approval for the remainer (RESCUED part) of this work (decision no.: 2018.579)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
In compliance with Dutch and European privacy legislation, the routine primary care registry data that support the findings of this study were used under strict license for the current study only, and so are not publicly available.
